Finding priorities for health research and development
- World Health Organisation
- Jan 20, 2017
- 1 min read
Today’s investments in health R&D are poorly aligned with global public health needs. As little as 1% of all funding for health R&D is allocated to diseases such as malaria and tuberculosis, although they account for more than 12% of the global disease burden. The WHO Global Observatory on Health R&D builds on existing data to enable decisions on R&D priorities.
The WHO Global Observatory on Health R&D (hereafter called “The Observatory”) is a centralized and comprehensive source of information and analyses on global health R&D activities for human diseases.
It builds on exisiting data and reports from a wide range of data sources, and gathers new information (where needed and feasible) with the aim of enabling decisions on priorities in R & D
In 2015, WHO announced a call for papers for a peer-reviewed journal series entitled 'Informing the Establishment of the WHO Global Observatory on Health Research and Development'. The call was launched in association with the establishment of the Observatory called for by WHO’s Member States in World Health Assembly resolution WHA66.22, as part of a strategic workplan to promote innovation, build capacity, improve access and mobilize resources to address diseases that disproportionately affect the world’s poorest countries. The first papers were published in Health Research Policy and Systems (HARPS) during 2015 to 2016. Additional papers will continue to be published. The Call is still open, and new contributions are welcome.
Comments